By Norma Erickson When Merck’s HPV (human papillomavirus) vaccine, Gardasil, was introduced in Andalucia, Spain in 2008, a full 58% of the 14-year old girls eligible to receive the series of three vaccinations did so, paid for by Spanish healthcare dollars. Two years later, after much controversy about potential side effects and efficacy issues that […]